Citadel Advisors’s Healthcare Capital Corp. Class A common stock HCCC Stock Holding History

Citadel Advisors’s Portfolio HCCC Stock Details HCCC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-485,536	Closed	-$4.79M	–	15215
2021 Q4	$4.79M	Sell	485,536 -968	-0.2%	-$9.58K	﹤0.01%	4359
2021 Q3	$4.8M	Sell	486,504 -28,856	-6%	-$283K	﹤0.01%	4378
2021 Q2	$4.97M	Buy	515,360 +136	+0%	+$1.32K	﹤0.01%	4445
2021 Q1	$4.98M	Buy	+515,224	New	+$5.02M	﹤0.01%	4268

Citadel Advisors's HCCC Position: Q1 2022 in Review

Citadel Advisors sold out of Healthcare Capital Corp. Class A common stock (HCCC) in Q1 2022, closing a stake of 485,536 shares — an estimated $4.79M sold.

Citadel Advisors first reported a position in HCCC in Q1 2021 and held it in 4 quarters. The position peaked at $4.98M in Q1 2021. 0 funds tracked by Wall St. Rank hold HCCC as of Q1 2022.

Citadel Advisors reported no remaining Healthcare Capital Corp. Class A common stock position as of Q1 2022 after selling out during the quarter.
Citadel Advisors sold 485,536 Healthcare Capital Corp. Class A common stock shares in Q1 2022, an estimated $4.79M.
Citadel Advisors first reported a position in Healthcare Capital Corp. Class A common stock in Q1 2021 and held it in 4 quarters.
Citadel Advisors's Healthcare Capital Corp. Class A common stock position peaked at $4.98M in Q1 2021.
0 funds tracked by Wall St. Rank held Healthcare Capital Corp. Class A common stock as of Q1 2022.

Based on Citadel Advisors's 13F filing for Q1 2022, filed 16 May 2022.